Guerbet (GBT.PA) traded down -0.83 % during a 24 hours period ending at 03:57 PM Central Europe on Monday 26th. One Guerbet stock can currently be bought for about EUR 5.96 on popular exchanges. Current supply of Guerbet stocks is 12.5 mn. Guerbet has a current market capitalization of EUR 75.2 mn and approximately EUR 18.7 k worth of Guerbet was traded on exchanges in the last 24 hours. Since last month end, Guerbet has traded -14.43 % down. Simple moving average of last 200 days is at EUR 9.7. The highest price of past 52 weeks was recorded at EUR 18.26 on 11/26/2025. 52 weeks low was at EUR 5.8 on 10/22/2026.

Here is how related stocks have performed in the past 24 hours:

  • St Dupont (DPT.PA) traded down -3.45 % and now trades at EUR 0.08. Current market capitalisation for St Dupont is EUR 79.3 mn. Current price/earnings ratio for St Dupont is 43.5.

  • Sensorion (ALSEN.PA) traded down -6.93 % and now trades at EUR 8.46. Sensorion has a market capitalisation of EUR 86.6 mn.

  • Gascogne (ALBI.PA) traded up 1.96 % and now trades at EUR 2.06. Current market capitalisation for Gascogne is EUR 78.3 mn.

  • Carbios (ALCRB.PA) traded down -0.78 % and now trades at EUR 5.11. Current market capitalisation for Carbios is EUR 85.7 mn.

  • Sogeclair (ALSOG.PA) traded up 0.72 % and now trades at EUR 27.3. Sogeclair has a market capitalisation of EUR 85.3 mn. Current price/earnings ratio for Sogeclair is 12.53.

About Guerbet

Guerbet SA is a health care equipment and supply company that specializes in conducting research, developing products, and providing various imaging solutions worldwide. The company produces a range of contrast media products, delivery systems, medical devices, and related solutions for use in CT and Cath Lab examinations, magnetic resonance imaging (MRI), and interventional imaging. These include Optiray, a low osmolar contrast medium; Xenetix, a low-osmolar iodined agent; Telebrix, a high osmolar contrast medium; Conray and MD high osmolar contrast medium products; high osmolar contrast medium, an ionic low osmolar contrast medium agent; Dotarem, a non-specific gadolinium-based contrast medium; Artirem products; and Optimark, a contrast medium. Additionally, Guerbet provides products for interventional imaging, including Lipiodol ethyl esters of iodined fatty acids of poppy seed oil; Vectorio, a classic transarterial chemoembolization mixing and injection system; and Patent Blue V, an injectable medium. Delivery systems and services are also part of their offerings, including injectors, consumables for various types of injectors, and Contrast&Care, a patient data management software. Guerbet SA distributes its products directly, through distributors and license-holders primarily to hospitals, clinics, radiology centers, purchasing pools, and wholesalers. The company was founded in 1926 and has its main office in Villepinte, France. Their webseite is www.guerbet.com , and they are listed on the NYSE Euronext Paris stock exchange.